Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans

Abstract The potential to treat diabetes by increasing beta-cell mass is driving a major effort to identify beta-cell mitogens. Demonstration of mitogen activity in human beta cells is frequently performed in ex vivo assays. However, reported disparities in the efficacy of beta-cell mitogens led us...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hasna Maachi, Julien Ghislain, Caroline Tremblay, Vincent Poitout
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0c5672ccf4384164a7461795c4eafad4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c5672ccf4384164a7461795c4eafad4
record_format dspace
spelling oai:doaj.org-article:0c5672ccf4384164a7461795c4eafad42021-12-02T15:49:53ZPronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans10.1038/s41598-021-90643-32045-2322https://doaj.org/article/0c5672ccf4384164a7461795c4eafad42021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90643-3https://doaj.org/toc/2045-2322Abstract The potential to treat diabetes by increasing beta-cell mass is driving a major effort to identify beta-cell mitogens. Demonstration of mitogen activity in human beta cells is frequently performed in ex vivo assays. However, reported disparities in the efficacy of beta-cell mitogens led us to investigate the sources of this variability. We studied 35 male (23) and female (12) human islet batches covering a range of donor ages and BMI. Islets were kept intact or dispersed into single cells and cultured in the presence of harmine, glucose, or heparin-binding epidermal growth factor-like growth factor (HB-EGF), and subsequently analyzed by immunohistochemistry or flow cytometry. Proliferating cells were identified by double labeling with EdU and Ki67 and glucagon, c-peptide or Nkx6.1, and cytokeratin-19 to respectively label alpha, beta, and ductal cells. Harmine and HB-EGF stimulated human beta-cell proliferation, but the effect of glucose was dependent on the assay and the donor. Harmine potently stimulated alpha-cell proliferation and both harmine and HB-EGF increased proliferation of insulin- and glucagon-negative cells, including cytokeratin 19-positive cells. Given the abundance of non-beta cells in human islet preparations, our results suggest that assessment of beta-cell mitogens requires complementary approaches and rigorous identification of cell identity using multiple markers.Hasna MaachiJulien GhislainCaroline TremblayVincent PoitoutNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hasna Maachi
Julien Ghislain
Caroline Tremblay
Vincent Poitout
Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
description Abstract The potential to treat diabetes by increasing beta-cell mass is driving a major effort to identify beta-cell mitogens. Demonstration of mitogen activity in human beta cells is frequently performed in ex vivo assays. However, reported disparities in the efficacy of beta-cell mitogens led us to investigate the sources of this variability. We studied 35 male (23) and female (12) human islet batches covering a range of donor ages and BMI. Islets were kept intact or dispersed into single cells and cultured in the presence of harmine, glucose, or heparin-binding epidermal growth factor-like growth factor (HB-EGF), and subsequently analyzed by immunohistochemistry or flow cytometry. Proliferating cells were identified by double labeling with EdU and Ki67 and glucagon, c-peptide or Nkx6.1, and cytokeratin-19 to respectively label alpha, beta, and ductal cells. Harmine and HB-EGF stimulated human beta-cell proliferation, but the effect of glucose was dependent on the assay and the donor. Harmine potently stimulated alpha-cell proliferation and both harmine and HB-EGF increased proliferation of insulin- and glucagon-negative cells, including cytokeratin 19-positive cells. Given the abundance of non-beta cells in human islet preparations, our results suggest that assessment of beta-cell mitogens requires complementary approaches and rigorous identification of cell identity using multiple markers.
format article
author Hasna Maachi
Julien Ghislain
Caroline Tremblay
Vincent Poitout
author_facet Hasna Maachi
Julien Ghislain
Caroline Tremblay
Vincent Poitout
author_sort Hasna Maachi
title Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
title_short Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
title_full Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
title_fullStr Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
title_full_unstemmed Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans
title_sort pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of langerhans
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0c5672ccf4384164a7461795c4eafad4
work_keys_str_mv AT hasnamaachi pronouncedproliferationofnonbetacellsinresponsetobetacellmitogensinisolatedhumanisletsoflangerhans
AT julienghislain pronouncedproliferationofnonbetacellsinresponsetobetacellmitogensinisolatedhumanisletsoflangerhans
AT carolinetremblay pronouncedproliferationofnonbetacellsinresponsetobetacellmitogensinisolatedhumanisletsoflangerhans
AT vincentpoitout pronouncedproliferationofnonbetacellsinresponsetobetacellmitogensinisolatedhumanisletsoflangerhans
_version_ 1718385672294760448